ライフサイエンスコーパス: cyclodextrin

1 anoencapsulation of Danube fish oils in beta-cyclodextrin.

2 ing neonatal cardiomyocytes with methyl-beta-cyclodextrin.

3 sterol stores were depleted with methyl-beta-cyclodextrin.

4 yl esters form inclusion complexes with beta-cyclodextrin.

5 f new crystalline phases not present in beta-cyclodextrin.

6 igh-surface-area, mesoporous polymer of beta-cyclodextrin.

7 ally prevented by cholesterol depletion with cyclodextrin.

8 or host-guest interaction capability of beta-cyclodextrin.

9 prepared from various omega-3 oils and beta-cyclodextrin.

10 alled carbon nanotubes assimilated with beta-cyclodextrin.

11 of aqueous mixtures of omega-3 oil and beta-cyclodextrin.

12 fts, similar to positive control methyl-beta-cyclodextrin.

13 due is anchored in the interior of the alpha-cyclodextrin.

14 from the film and then solubilized with beta-cyclodextrin.

15 ed by its inclusion in the cavity of a gamma-cyclodextrin.

16 ch has a lower binding affinity toward alpha-cyclodextrin.

17 te in today's gold mining industry, by alpha-cyclodextrin.

18 ius [28]hexaphyrin doubly linked to an alpha-cyclodextrin.

19 ther deionized water or aqueous solutions of cyclodextrins.

20 aniline or naphthalene moieties of ANS with cyclodextrins.

21 rcome by using encapsulating systems such as cyclodextrins.

22 using aqueous solution of hydroxypropyl-beta-cyclodextrins.

23 ee classes of probes including those made of cyclodextrins, 1,1'-binaphthyl compounds, and nanomateri

24 ids were complexed with 2-hydroxypropyl-beta-cyclodextrin (2-HPbetaCD) in different mass ratios (1:4,

25 CN)(2)Calpha-cyclodextrin, KAu(CN)(2)C(alpha-cyclodextrin)(2), and KAg(CN)(2)C(alpha-cyclodextrin)(2)

26 lpha-cyclodextrin)(2), and KAg(CN)(2)C(alpha-cyclodextrin)(2)-demonstrate that the binding cavity of

27 ependent methods: 1) exposure to methyl-beta-cyclodextrin, 2) treatment with the HMG-CoA reductase in

28 e, we demonstrated that 2-hydroxypropyl-beta-cyclodextrin, a clinical agent used to enhance the solub

29 mice were treated with 2-hydroxypropyl-beta-cyclodextrin, a drug previously reported to rescue Purki

30 al neurodegeneration, and we reveal how beta-cyclodextrin, a potential therapeutic drug, reverts thes

31 ented by treatment with 2-hydroxypropyl-beta-cyclodextrin, a promising therapy currently under clinic

32 ed heparan sulfate analogue, and by sulfated cyclodextrin, a sulfated small molecule.

33 ell-known cholesterol extracting agent, beta-cyclodextrin, acts by catalytically tipping the equilibr

34 ose of activated carbons and non-porous beta-cyclodextrin adsorbent materials.

35 no acid enantiomers were resolved with gamma-cyclodextrin alone.

36 ents of the chemistry of naturally occurring cyclodextrins, along with a variety of synthetic flexibl

37 This study aims to characterize CO2-alpha-cyclodextrin (alpha-CD) inclusion complexes produced fro

38 r-induced crystallization of amorphous alpha-cyclodextrin (alpha-CD) powder on CO2 encapsulation at 0

39 matrices of amorphous and crystalline alpha-cyclodextrin (alpha-CD) powders, under various pressures

40 perties in which the azobenzene motif, alpha-cyclodextrin (alpha-CD), and ionic liquid are grafted on

41 lent complexes of folic acid (FA) and native cyclodextrins (alpha-CD, beta-CD, and gamma-CD).

42 Here we describe the encapsulation in alpha-cyclodextrins (alpha-CDs) of wheat bran, pumpkin and tom

43 in, as free oil or as ready-to-mix oil/alpha-cyclodextrins (alpha-CDs) powder, was explored.

44 Insoluble polymers of beta-cyclodextrin, an inexpensive, sustainably produced macro

45 r (calorimetric effect of 536Jg(-1) for beta-cyclodextrin and 304-422.5Jg(-1) for complexes).

46 e supramolecular hydrogel (SH) made of alpha-cyclodextrin and 4-arm polyethylene glycol via host-gues

47 the 2:1 binding stoichiometry between alpha-cyclodextrin and Au(CN)(2)(-) is favored in the presence

48 ctivity was only moderately affected by beta-cyclodextrin and bovine serum albumin, taken as models o

49 binding epitopes are capable of binding beta-cyclodextrin and cucurbit[6/7]uril (CB) simultaneously t

50 the supramolecular interactions between beta-cyclodextrin and ferrocene-nucleobase derivatives.

51 molecular recognition process between alpha-cyclodextrin and KAu(CN)(2) can be applied to the stripp

52 es a background electrolyte containing gamma-cyclodextrin and sodium taurocholate micelles.

53 ivation was also decreased after methyl-beta-cyclodextrin and statin treatment but increased in cells

54 axane hydrogels, which are composed of alpha-cyclodextrins and poly(ethylene oxide)-poly(propylene ox

55 riven by host-guest interactions between the cyclodextrins and the target molecule, we observe these

56 can accommodate into the hydrophobic core of cyclodextrins and therefore, they are protected from exo

57 erparamagnetic iron oxide nanoparticle, beta-cyclodextrin, and polymerized paclitaxel.

58 beta-Cyclodextrin- and 2-hydroxypropyl-beta-cyclodextrin/Danu

59 Hydroxypropyl-beta-cyclodextrin/ANE (HP-beta-CD/ANE) inclusion complexes we

60 Chitosan chloride and methyl-beta-cyclodextrins appear therefore suitable to formulate sol

61 Cyclodextrins are cyclic glucan oligosaccharides that fo

62 Cyclodextrins are cyclic oligosaccharides widely used in

63 Cyclodextrins are substances well known for their abilit

64 r acute cholesterol depletion by methyl-beta-cyclodextrin as a tool to describe the physiological rol

65 g a direct compaction grade powder with beta-cyclodextrin as encapsulating agent.

66 e bottom with inclusion complexes (ICs) of B-cyclodextrin (B-CD) containing the essential oils of pal

67 For this purpose, a chiral host, beta-Cyclodextrin based copper metal organic framework (CD-Cu

68 Thus, the optimization of the beta-cyclodextrin-based extraction of functional compounds fr

69 breast cancer model than the currently used cyclodextrin-based formulation.

70 e findings demonstrate the promise of porous cyclodextrin-based polymers for rapid, flow-through wate

71 es, functionalized with a pH-responsive beta-cyclodextrin-based supramolecular nanovalve on the MS su

72 tive molarity for binding the flexible alpha-cyclodextrin-based template within the six-porphyrin nan

73 Cyclic oligosaccharide 2-hydroxypropyl-beta-cyclodextrin (BCD) is a compound that solubilizes lipoph

74 nsitive host-guest crosslinkers between beta-cyclodextrin (beta-CD) and ferrocene (Fc) and iron chela

75 The beta-cyclodextrin (beta-CD) capped ZnO quantum dots (QDs) wer

76 ral and thermodynamic insights into the beta-cyclodextrin (beta-CD) encapsulation of key compounds in

77 In this study, beta-cyclodextrin (beta-CD) enhanced ultrasound assisted extr

78 In this paper, beta-cyclodextrin (beta-CD) supported on porous graphene nano

79 purees through molecular inclusion with beta-cyclodextrin (beta-CD) was assessed.

80 irect complexation with solid amorphous beta-cyclodextrin (beta-CD) was investigated.

81 ion complexes of 2-nonanone (2-NN) with beta-cyclodextrin (beta-CD), were prepared by a co-precipitat

82 Here we report a beta-cyclodextrin (beta-CD)-based polymer network with higher

83 ht-responsive host-guest complexes with beta-cyclodextrin (beta-CD).

84 clic hosts, cucurbit[7]uril (CB[7]) and beta-cyclodextrin (beta-CD).

85 erials, i.e. brown rice flour (BRF) and beta-cyclodextrin (beta-CD).

86 has good affinity for a model receptor, beta-cyclodextrin (beta-CD).

87 Different wall materials like beta-cyclodextrin (beta-cyd), whey protein isolate (WPI) and

88 of CAB formulated with 2-hydroxypropyl-beta-cyclodextrin (betaCAB) and examined the pharmacokinetics

89 LyeTxI and association compound LyeTxI/beta-cyclodextrin (betaCD) against multispecies biofilms.

90 olysin (alphaHL) to map the presence of beta-cyclodextrin (betaCD) at a substrate pore opening.

91 ble sport beverage, with and without 2% beta-cyclodextrin (betaCD) under light and darkness condition

92 le acid that exhibits strong binding to beta-cyclodextrin (betaCD).

93 This study focuses on the effect of beta-cyclodextrins (betaCyD) on PPO-catalyzed reactions.

94 ceptor/product, which overlap with the known cyclodextrin binding site.

95 or hydrophobic interactions in the cationic cyclodextrin binding.

96 improve the response to 2-hydroxypropyl-beta-cyclodextrin, by restoring a functional NPC1 to the chol

97 we present the use of supramolecular hosts (cyclodextrins, calixarenes, (acyclic) cucurbiturils, and

98 capture of olive pheromones inside the beta-cyclodextrin cavity leads to the reduction of resonant f

99 ridine ring of folic acid remain outside the cyclodextrin cavity, while the glutamate residue is anch

100 ive capture synthesis, whereby introducing a cyclodextrin (CD) as an accelerator in CB-AAC, hydrogen

101 cterization of the rosmarinic acid (RA)-beta-cyclodextrin (CD) complex in aqueous solution by (1)H NM

102 Herein we show that by appending bulky beta-cyclodextrin (CD) groups onto sheet-forming peptoids, we

103 F4:Yb/Tm/Er UCNP through an azobenzene (Azo)-cyclodextrin (CD) host-guest interaction.

104 een a carbohydrate-based molecule and a beta-cyclodextrin (CD) hydrophobic cavity for asymmetric cata

105 Novel cyclodextrin (CD)-based amphiphilic poly(carboxylic acid

106 s prepared from DOTAP and carboxymethyl-beta-cyclodextrin (CD).

107 rawback could be overcome by complexation in cyclodextrins (CD) or cosolvency.

108 The level of released cyclodextrins (CD) was assessed, besides the microstruct

109 In vivo, chitosan-loaded cyclodextrin (CDPE-Cs) hydrogels yield significantly low

110 Cyclodextrins (CDs) are known molecular encapsulators an

111 cal C-H functionalization to access modified cyclodextrins (CDs) has been developed.

112 In this sense, cyclodextrins (CDs) have been widely used to solve these

113 t bis(1,2-dicarbollide) anions (COSANs) with cyclodextrins (CDs) in aqueous solution.

114 Effects of the encapsulation in cyclodextrins (CDs) on the solubility, photostability an

115 Molecular inclusion of OTA by cyclodextrins (CDs) results in complexes with low stabil

116 The capacity of cyclodextrins (CDs) to extract phenolic compounds from g

117 with high biological activity) and modified cyclodextrins (CDs) was studied.

118 alpha-, beta-, and gamma-cyclodextrins (CDs) were modified on their secondary fac

119 Readily available cyclodextrins (CDs) with an inherent hydrophobic interna

120 Among cyclodextrins (CDs), methyl beta cyclodextrin (MbetaCD)

121 ; this could be resolved by encapsulation in cyclodextrins (CDs).

122 amin inhibitors, chlorpromazine, methyl-beta-cyclodextrin, chloroquine, and concanamycin A dramatical

123 ne-iodine, chlorhexidine, hydrogen peroxide, cyclodextrin, Citrox, cetylpyridinium chloride, and esse

124 tion and bioelectrocatalysis of redox-active cyclodextrin-coated nanoparticles.

125 ch, the first examples of close analogues of cyclodextrins composed of d-glucose residues and triazol

126 d biguanidyl adamantine (Ad-SS-GD) with beta-cyclodextrin-conjugated low-molecular-weight polyethylen

127 ivalent host-guest interactions between beta-cyclodextrin-conjugated superparamagnetic iron oxide nan

128 ecent success using synthetic derivatives of cyclodextrins, cucurbiturils, and various organic cyclop

129 2-hydroxypropyl-beta-cyclodextrin (CYCLO), a modifier of cholesterol efflux f

130 beta-Cyclodextrin- and 2-hydroxypropyl-beta-cyclodextrin/Danube common nase (Chondrostoma nasus L.)

131 The moisture content of beta-cyclodextrin/Danube fish oils complexes (common barbel,

132 nger interactions between the target and the cyclodextrin decrease the rate of target diffusion.

133 oxylate displaces the metal complex from the cyclodextrin decreasing the reactivity.

134 re we measured the rate at which methyl-beta-cyclodextrin depletes cholesterol from a supported lipid

135 concentration as cholesterol depletion using cyclodextrins did not alter inflammatory responses.

136 nthesized by varying the molar ratio of beta-cyclodextrin:diphenyl carbonate (beta-CD:DPC; 1:2, 1:6 a

137 asites with cholesterol-specific methyl-beta-cyclodextrin disrupts both membrane liquid order and loc

138 A combined approach based on cyclodextrin/drug inclusion complex formation and loadin

139 lso show that seven- and eightfold symmetric cyclodextrins effectively block the heptameric and octam

140 the primary and secondary OH groups of beta-cyclodextrin exhibit markedly different dynamics, sugges

141 Cyclodextrin extractions, sorptive bioaccessibility extr

142 ifferent chirality elements arising from the cyclodextrin (fix central chirality), the bridging patte

143 frared fluorophores for bioimaging, and beta-cyclodextrins for potential drug delivery.

144 s (1 mM cholesterol@randomly methylated-beta-cyclodextrin) for transport assays.

145 omarker avoiding the use of additives (i.e., cyclodextrins) for enantiomeric separation as well as an

146 mits, are strongly dependent on the specific cyclodextrin forming the gradient.

147 By using a cyclodextrin framework the polymerization of pyrrole is

148 f HSV-1-infected Vero cells with methyl beta-cyclodextrin from 2 to 9 h postentry reduced plaque numb

149 rategy for controlled synthesis of thio-beta-cyclodextrin functionalized graphene/gold nanoparticles

150 Poly(beta-cyclodextrin functionalized ionic liquid) immobilized ma

151 hemical sensor using graphene oxide and beta-cyclodextrin functionalized multiwalled carbon nanotubes

152 ining either cyclodextrin vesicles (CDVs) or cyclodextrin-functionalized gold nanoparticles (CDAuNPs)

153 newable framework material composed of gamma-cyclodextrin (gamma-CD) and alkali metal salts--namely,

154 allization of K(+) and Li(+) ions with gamma-cyclodextrin (gamma-CD) has been shown to substitute the

155 cinnamates using a catalytic amount of gamma-cyclodextrin (gamma-CD) in water has been developed to g

156 ected charged SDS micelles and neutral gamma-cyclodextrin (gamma-CD) zones, where the analytes bound

157 -rich cluster [Ta6Br12(H2O)6](2+), and gamma-cyclodextrin (gamma-CD).

158 formation of inclusion complexes with gamma-cyclodextrin (gamma-CD).

159 nsist of an extended porous network of gamma-cyclodextrins (gamma-CDs) and alkali metal cations, can

160 Thymol (THY)/gamma-Cyclodextrin(gamma-CD) inclusion complex (IC) encapsulat

161 alled carbon nanotubes assimilated with beta-cyclodextrin/glassy carbon electrode exhibited catalytic

162 f native and extruded wheat flours combining cyclodextrin glucanotransferase and extrusion treatments

163 radially symmetric alpha-, beta-, and gamma-cyclodextrin gradients in a hydrogel matrix.

164 Cyclodextrins have been shown to reverse lipid accumulat

165 alpha- and beta-cyclodextrins have been used as scaffolds for the synthe

166 Cyclodextrins have been used for decades to improve the

167 luble azobenzene and alpha-, beta-, or gamma-cyclodextrins, have been proposed as a model to study su

168 ) via controlled esterification or with beta-cyclodextrins (host moieties) through amidation.

169 y, were spray-dried using hydroxypropyl-beta-cyclodextrin (HP-beta-CD) and inulin (IN).

170 the cycloheptaglucoside 2-hydroxypropyl-beta-cyclodextrin (HP-beta-CD) has shown efficacy as a potent

171 mpact and hard HS tissue, hydroxypropyl-beta-cyclodextrin (HP-beta-CD) was added into sodium hyaluron

172 Curcumin/Hydroxypropyl-beta-Cyclodextrin (HP-beta-CyD) and Curcumin/Hydroxypropyl-ga

173 P-beta-CyD) and Curcumin/Hydroxypropyl-gamma-Cyclodextrin (HP-gamma-CyD) inclusion complex nanofibrou

174 omes was investigated using hydroxypropyl-ss-cyclodextrin (HP-ss-CD) as membrane protectant.

175 s solubility and stability using hydropropyl-cyclodextrins (HP-CDs) and bile salts.

176 h maltodextrin (MD) and 2-hydroxypropyl-beta-cyclodextrin (HPBCD).

177 2-Hydroxypropyl-beta-cyclodextrin (HPbetaCD) is a Food and Drug Administratio

178 n combines this drug with hydroxypropyl-beta-cyclodextrin (HPbetaCD) to improve its solubility and to

179 eported ototoxicity of 2-hydroxypropyl- beta-cyclodextrin (HPbetaCD), a cholesterol chelator and the

180 2-Hydroxy-propyl-beta-cyclodextrin (HPbetaCD), a cholesterol scavenger, is cur

181 and Gallic acid (GA) with 2-hydroxypropyl-b-cyclodextrin (HPbetaCD), by the spray-drying method, wer

182 urthermore, we utilized 2-hydroxypropyl-beta-cyclodextrin (HPbetaCD, an emerging therapeutic) adminis

183 Three types of modified cyclodextrin (HPbetaCD, MbetaCD, and HPgammaCD) were use

184 In preclinical testing, 2-hydroxypropyl-beta-cyclodextrins (HPbetaCD) significantly delayed cerebella

185 We employed 2-hydroxypropyl)-beta-cyclodextrin (HPCD), which was dissolved in water to inc

186 boratories showed that 2-hydroxypropyl-gamma-cyclodextrin (HPgammaCD) alleviates cholesterol accumula

187 om long chain ionic surfactants) and neutral cyclodextrins (i.e., native alpha-, beta-, or gamma-cycl

188 This study shows a natural example of cyclodextrins improving the solubility and efficacy of a

189 The adduct formation of KAu(CN)(2)Calpha-cyclodextrin in aqueous solution is sustained by multipl

190 stoichiometry between Au(CN)(2)(-) and alpha-cyclodextrin in aqueous solution, revealed by (1)H NMR t

191 (composed of sodium dodecyl sulfate and beta-cyclodextrin) in a spatially resolved manner.

192 cid (PAA) nanofibres (NF) incorporating beta-cyclodextrin inclusion complex (beta-CD-IC) of quercetin

193 ment in the thermal stability of linalool by cyclodextrin inclusion complexation.

194 lly, three chiral compounds and three chiral cyclodextrin-incorporated OTCs were evaluated at high te

195 glutathione thiyl radical (GS(*)); (ii) beta-cyclodextrins increase the kinetic stability of the spin

196 s of this study show that carboxymethyl-beta-cyclodextrin increased lipoplexes' encapsulation efficie

197 leting cellular cholesterol with methyl-beta-cyclodextrin increased the resilience of stromal cells t

198 crystalline phases not present in pure beta-cyclodextrin, indicating true complexation.

199 lls with cholesterol-deficient media or beta-cyclodextrins induced changes in cholesterol distributio

200 led that the therapeutic drug candidate beta-cyclodextrin induces the subplasmalemmal location of lam

201 Last, we found that 2-hydroxypropyl-beta-cyclodextrin inhibits AAA in a VSMC TFEB-dependent manne

202 Cyclodextrin insulation of the conjugated backbone impro

203 only the suggested Coulomb component of the cyclodextrin interaction remains.

204 Poly(beta-cyclodextrin-ionic liquid) grafted magnetic nanoparticle

205 demonstrate that the binding cavity of alpha-cyclodextrin is a good fit for metal-coordination comple

206 beta-cyclodextrin is known to encapsulate pollutants to form

207 xtrins (i.e., native alpha-, beta-, or gamma-cyclodextrin) is presented.

208 gle-crystal superstructures-KAu(CN)(2)Calpha-cyclodextrin, KAu(CN)(2)C(alpha-cyclodextrin)(2), and KA

209 spinning of polymer-free nanofibrous webs of cyclodextrin/linalool-inclusion complex (CD/linalool-IC-

210 Methyl-alpha-cyclodextrin, loaded with exogenous lipids, was used to

211 olve this problem, we show that methyl-alpha-cyclodextrin (MalphaCD)-catalyzed lipid exchange can be

212 TFEB activation by 2-hydroxypropyl-beta-cyclodextrin may be a promising therapeutic strategy for

213 Among cyclodextrins (CDs), methyl beta cyclodextrin (MbetaCD) is the most efficient to deplete

214 the cholesterol-extracting agent methyl-beta-cyclodextrin (MbetaCD) not only disrupted the DRM locali

215 Cholesterol depletion by methyl-beta-cyclodextrin (MbetaCD) remodels the plasma membrane's me

216 Treatment of cells with methyl-beta-cyclodextrin (MbetaCD) significantly reduced the DRM ass

217 To test this hypothesis, we used methyl-beta-cyclodextrin (MbetaCD) to load mouse peritoneal macropha

218 afts, we pretreated animals with methyl-beta-cyclodextrin (MbetaCD), which disrupts lipid rafts.

219 ere depleted of cholesterol with methyl-beta-cyclodextrin (mbetaCD).

220 tment with lipid raft disruptor (Methyl-beta-cyclodextrin, MbetaCD) and oxidative stress inhibitor (N

221 Lipid raft/caveolae disruptors (methyl-beta-cyclodextrin (MCD) and Nystatin) and Ang II stimulation

222 In parallel, beta-cyclodextrin mediated the NPC1-independent redistributio

223 Here, a method based on cyclodextrin-mediated lipid exchange to characterize the

224 rcumin has been successfully encapsulated in cyclodextrin-metal organic frameworks (CD-MOFs) without

225 extrin, per-6-S-(3-aminomethyl) benzyl-gamma-cyclodextrin, methyltriphenylphosphonium ion, and G0 pol

226 Spherical chitosan chloride and methyl-beta-cyclodextrin microparticles loaded with DFO (DCH and MCD

227 brane cholesterol depletion with methyl-beta-cyclodextrin mimicked the effects of AC6 silencing on PA

228 Perspective includes synthetic porphyrinoid-cyclodextrin models of proteins participating in fundame

229 ted with the increasing availability of beta-cyclodextrin moieties over the surface of the devices an

230 QD functionalization with beta-cyclodextrin molecular baskets enables loading and deliv

231 nt equipped with a noncovalently bound gamma-cyclodextrin molecule as a stochastic sensor.

232 The aim of this work was to synthesize beta-cyclodextrin NS, by microwave-assisted fusion, for the e

233 ond type interaction between the OH group of cyclodextrin of CD-MOFs and the phenolic hydroxyl group

234 ibility of synthesizing NS derived from beta-cyclodextrin of high crystallinity for the encapsulation

235 properties by blocking the peptide pores by cyclodextrins of different charge and symmetry.

236 Depletion of cholesterol through methyl-beta-cyclodextrin or cholesterol oxidase abolished the protec

237 by lipid raft perturbation using methyl-beta-cyclodextrin or cholesterol oxidase.

238 ANS complexation by cyclodextrins or bovine serum albumin (BSA) results in a

239 that it does not bind to starch mimics, beta-cyclodextrin, or maltohexaose.

240 rs that attached the drug payloads to a beta-cyclodextrin-PEG copolymer to form self-assembled nanopa

241 ockers, namely per-6-S-(3-amino) propyl-beta-cyclodextrin, per-6-S-(3-aminomethyl) benzyl-alpha-cyclo

242 extrin, per-6-S-(3-aminomethyl) benzyl-alpha-cyclodextrin, per-6-S-(3-aminomethyl) benzyl-beta-cyclod

243 dextrin, per-6-S-(3-aminomethyl) benzyl-beta-cyclodextrin, per-6-S-(3-aminomethyl) benzyl-gamma-cyclo

244 and then reacted with per-O-methylated beta-cyclodextrin (PMbetaCD) caps, to form supramolecular syn

245 tic material, namely, poly(p-phenylene) beta-cyclodextrin poly(ethylene glycol) (PPP-CD-g-PEG) combin

246 In the current study, beta-cyclodextrin polyester (CDPE) hydrogels serve as sacrifi

247 A beta-cyclodextrin polymer linked with tetrafluoroterephthalon

248 , we evaluated the performance of three beta-cyclodextrin polymers (CDPs), an anion-exchange (AE) res

249 s to evaluate the performance of porous beta-cyclodextrin polymers (P-CDP) as adsorbents of MPs in aq

250 t complexes, but until now cross-linked beta-cyclodextrin polymers have had low surface areas and poo

251 Moreover, engineered cyclodextrin-porphyrinoid assemblies enhance the photody

252 Cyclodextrins, provide a hydrophobic cavity in the core

253 we demonstrate that quaternary ammonium beta-cyclodextrin (QABCD) fulfils both of these requirements.

254 crobial activity of randomly methylated beta cyclodextrin (RAMEB) encapsulated thyme oil, lemon balm

255 Ae. aegypti cells with 2-hydroxypropyl-beta-cyclodextrin restores dengue replication in Wolbachia-ca

256 ation of compound 2 in PLGA nanoparticles or cyclodextrins resulted in lower in vitro toxicity when c

257 gins, using chiral gas chromatography (gamma-cyclodextrin), revealing the exclusive presence of the S

258 Disruption of lipid rafts with cyclodextrin reversed the phenotype.

259 y coupling reduced graphene oxide with gamma-cyclodextrin (rGO/gamma-CD).

260 By switching the motion of the alpha-cyclodextrin rings between random shuttling and stationa

261 t of the conjugates interacted with the beta-cyclodextrin's inner cavity.

262 at is palmitoylated and mediates methyl-beta-cyclodextrin-sensitive self-association of purified gB.

263 micellar solution followed by injection of a cyclodextrin solution zone, and then separation by co-el

264 eation of alpha-cyclodextrin through CymA, a cyclodextrin-specific channel from Klebsiella oxytoca.

265 Analyte focusing by micelle to cyclodextrin stacking (MCDS) in micellar electrokinetic

266 Inclusion of CHAs with beta-cyclodextrin strongly limited these interactions to a le

267 est score (5/8) along with complexation with cyclodextrin suggesting that these methods are the most

268 eversal is caused by the formation of stable cyclodextrin-surfactant complexes at the boundary that s

269 he biochars were subjected to (1) an aqueous cyclodextrin suspension with a contaminant trap as (infi

270 In addition, since porphyrinoid-cyclodextrin systems comprise third generation photosens

271 uble drugs than was previously possible with cyclodextrin technology.

272 ic Rhodamine B as acceptors that insert into cyclodextrin, the micelles exhibit highly efficient Fors

273 ore by investigating the permeation of alpha-cyclodextrin through CymA, a cyclodextrin-specific chann

274 of the EOF when analyzing the penetration of cyclodextrins through the CymA pore.

275 The addition of carboxymethyl-beta-cyclodextrin to cationic liposomes resulted in an increa

276 been synthesized by covalently linking beta-cyclodextrin to the surface of N, S codoped carbon dots

277 esidue, (ii) site-specifically adhering beta-cyclodextrin to the surface of ubiquitin, and (iii) sele

278 The capacity of cyclodextrins to include hydrophobic molecules in their

279 Some cells were incubated with methyl-beta-cyclodextrin (to deplete cholesterol from membranes) or

280 K(+) ions fulfill the role of linking alpha-cyclodextrin tori together as a result of [K(+)...O] ion

281 depleting endogenous 7-DHC with methyl-beta-cyclodextrin treatment enhances Hedgehog activation by a

282 ed to approximately 79 pN/mum by methyl-beta-cyclodextrin treatment to sequester membrane cholesterol

283 awson-type [P2W18O62](6-) anion by two gamma-cyclodextrin units.

284 aints imposed on them, and the properties of cyclodextrin used as a cholesterol donor.

285 ed supramolecular systems, containing either cyclodextrin vesicles (CDVs) or cyclodextrin-functionali

286 lymer-shelled vesicles are prepared by using cyclodextrin vesicles as supramolecular templates and an

287 f the title compound in the presence of beta-cyclodextrin was examined in different conditions.

288 Cy3-labeled cyclodextrins were immobilized on a glass surface as a s

289 or goal was to develop a chemically modified cyclodextrin which gives a more stable complex with OTA

290 een bound water and the secondary OH of beta-cyclodextrin, which exhibited spatial uniformity within

291 dentified by NMR as alpha-, beta-, and gamma-cyclodextrins, which undergo acetylation.

292 atest when the gradient is formed using beta-cyclodextrin while directed concentration of cyanomethyl

293 Here we crosslink beta-cyclodextrin with rigid aromatic groups, providing a hig

294 Measurements of interaction times of alpha-cyclodextrin with RNTPs reveal two distinct unbinding ti

295 st that interactions of either face of alpha-cyclodextrin with the RNTP face are differentiable, back

296 evertheless mediates efficient OM passage of cyclodextrins with diameters of up to approximately 15 A

297 nist or disrupting caveolae with methyl-beta-cyclodextrin, with an associated approximately 30% whole

298 n complexes of Vitamin A Palmitate with beta-cyclodextrins, without the use of organic solvents, is d

299 Formulation of 4c with hydroxypropyl-beta-cyclodextrin yielded good oral bioavailability, encourag

300 The dynamic boundary was formed at the cyclodextrin zone as the micelles penetrated this zone.